These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9755802)

  • 1. The clinical role of growth factors in the treatment of breast cancer.
    Fetscher S; Mertelsmann R
    Biomed Pharmacother; 1998; 52(3):101-8. PubMed ID: 9755802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of hematopoietic growth factors to support cytotoxic chemotherapy for patients with breast cancer.
    Demetri GD
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):233-49. PubMed ID: 8150782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factors in the management of adult acute leukemia.
    Bernstein SH
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):255-74. PubMed ID: 8449861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic growth factors in cancer chemotherapy.
    Crawford J; Foote M; Morstyn G
    Cancer Chemother Biol Response Modif; 1999; 18():250-67. PubMed ID: 10800487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic growth factors--an overview.
    Golde DW
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():4-10. PubMed ID: 2182745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dense chemotherapy for primary breast cancer.
    Kümmel S; Rezai M; Kimmig R; Schmid P
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):75-81. PubMed ID: 17218856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient management strategies and transplantation techniques in european stem cell transplantation centers offering breast cancer patients high-dose chemotherapy with peripheral blood stem cell support: a joint report from the EORTC and EBMT.
    Neymark N; Rosti G
    Haematologica; 2000 Jul; 85(7):733-44. PubMed ID: 10897126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy.
    Cheng YC; Rondón G; Yang Y; Smith TL; Gajewski JL; Donato ML; Shpall EJ; Jones R; Hortobagyi GN; Champlin RE; Ueno NT
    Biol Blood Marrow Transplant; 2004 Nov; 10(11):794-804. PubMed ID: 15505610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
    Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
    Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of hematopoietic growth factor prescriptions in 19 french cancer centers].
    Gautié L; Canal P; Menguy A; Latour JF; Bénard I; Courbard M; Brunelle P; Carpentier Y; Pinguet F; Chevrier R; Doly M; Watelet M; Brière M; Viau P; Duban M; German O; Gosselin P; de La Jarriage PL; Bertrand C; Pommier M; Prebay D
    Bull Cancer; 1998 Dec; 85(12):1043-8. PubMed ID: 9917555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New strategies for management of oral mucositis in cancer patients.
    Peterson DE
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):9-13. PubMed ID: 16499139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
    Grossi F; Tiseo M
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of advanced breast cancer: current issues].
    Tajima T; Tokuda Y; Kubota M
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1832-40. PubMed ID: 9797805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour epidermal growth factor receptor, erbB-2 and cathepsin D in node-negative invasive breast cancer: their impact on the selection of patients for systemic adjuvant therapy.
    Tonkin KS; McKay JW; Stitt LW; Tokmakejian S; Haines DS
    Cancer Prev Control; 1999 Apr; 3(2):131-6. PubMed ID: 10474760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications.
    Ferrandina G; Pierelli L; Perillo A; Rutella S; Ludovisi M; Leone G; Mancuso S; Scambia G
    Clin Cancer Res; 2003 Jan; 9(1):195-200. PubMed ID: 12538469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer.
    Bilgrami S; Feingold JM; Bona RD; Edwards RL; Khan AM; Rodriguez-Pinero F; Khan IA; Kazierad D; Clive J; Tutschka PJ
    Bone Marrow Transplant; 2000 Jan; 25(2):123-30. PubMed ID: 10673668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer.
    Wong R; Rondon G; Saliba RM; Shannon VR; Giralt SA; Champlin RE; Ueno NT
    Bone Marrow Transplant; 2003 Jun; 31(12):1157-63. PubMed ID: 12796796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral progenitor cells (PBPC) in supportive care after high-dose chemotherapy in breast cancer.
    Filip S; Bláha M; Petera J; Vavrová J; Knízek J
    Neoplasma; 2001; 48(1):39-47. PubMed ID: 11327536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
    Shi Y; Pan F; Han X
    Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.